Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease

The voxel‐based morphometry (VBM) technique using brain magnetic resonance imaging (MRI) objectively maps gray matter loss on a voxel‐by‐voxel basis after anatomic standardization. In patients with Alzheimer's disease (AD), reductions of gray matter volume, mainly in the medial temporal structures, have been reported; however, inhomogeneity and geometric distortion of the field intensity hampers the reproducibility of MRI. In the present study, we developed a novel computed tomography (CT)‐based VBM method and used this technique to detect volume loss in AD patients as compared with normal controls. The results were compared with MRI‐based VBM using the same subjects. Pittsburgh Compound B (11C‐PIB) positron emission tomography (PET)/CT was performed and two experts in neuro‐nuclear medicine judged whether regional amyloid β load was consistent with a diagnosis of AD. Before the injection of 11C‐PIB, high‐quality CT scans were obtained using the same PET/CT equipment. MRI was performed within a mean interval of 25.1 ± 8.2 days before the PET/CT scan. Using statistical parametric mapping 8 (SPM8), the extracted gray matter images from CT and MRI were spatially normalized using a gray matter template and smoothed using a Gaussian kernel. Group comparisons were performed using SPM8 between five 11C‐PIB‐positive patients with probable AD and seven 11C‐PIB‐negative age‐matched controls with normal cognition. Gray matter volumes in the bilateral medial temporal areas were reduced in the AD group as compared with the cognitively normal group in both CT‐based VBM (in the left; P < 0.0001, cluster size 2776 and in the right; P < 0.0001, cluster size 630) and MRI‐based VBM (in the left; P < 0.0001, cluster size 381 and in the right, P < 0.0001, cluster size 421). This newly developed CT‐based VBM technique can detect significant atrophy in the entorhinal cortex in probable AD patients as previously reported using MRI‐based VBM. However, CT‐VBM was more sensitive and revealed larger areas of significant atrophy than MR‐VBM.

[1]  福山 秀直,et al.  SPM(statistical parametric mapping)の概要とその応用 (特集:核医学の新潮流) , 1998 .

[2]  E. Biojsen,et al.  MRI--magnetic resonance imaging. , 1987, Medical electronics.

[3]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[4]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Takashi Asada,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2005, Neuroscience Letters.

[6]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[7]  A. W. Toga,et al.  3D maps localize caudate nucleus atrophy in 400 Alzheimer’s disease, mild cognitive impairment, and healthy elderly subjects , 2010, Neurobiology of Aging.

[8]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[9]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[10]  Jeih-San Liow,et al.  Qualitative and Quantitative Evaluation of Six Algorithms for Correcting Intensity Nonuniformity Effects , 2001, NeuroImage.

[11]  Emma J. Burton,et al.  A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.

[12]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[13]  Kuncheng Li,et al.  Voxel-based assessment of gray and white matter volumes in Alzheimer's disease , 2010, Neuroscience Letters.

[14]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[15]  T. Ohnishi,et al.  Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? , 2001, AJNR. American journal of neuroradiology.

[16]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[17]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[18]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[19]  Chunshui Yu,et al.  Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta‐analyses of MRI studies , 2009, Hippocampus.

[20]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[21]  Karl J. Friston,et al.  False discovery rate revisited: FDR and topological inference using Gaussian random fields , 2009, NeuroImage.